View Press Releases

Alta Stomatology Introduces Scientific Platforms to Advance Oral Disease Drug Development

August 21, 2024

New York, United States—August 22, 2024—Alta Stomatology, a company specializing in oral disease research, is proud to announce the introduction of advanced scientific platforms that aim to advance drug development for treating oral diseases.

 

Oral disease research focuses on the causes, diagnosis, and drug development for periodontal disease, dental caries, oral cancer, temporomandibular disorders (TMD), and other oral conditions. Oral disease drug development is the process of creating and testing new drugs to treat these conditions. It typically involves drug discovery, preclinical testing in laboratory settings, clinical trials in human subjects, and regulatory approval by agencies, which is a challenging and costly process. 

 

Alta Stomatology specializes in oral disease research to advance oral health. With a commitment to staying at the forefront of dental research and technology, Alta Stomatology has invested in state-of-the-art equipment and technology to enhance oral disease drug development. So far, the company has established oral microbial research platform, cell biology research platform, oral immunity & infection research platform, molecular genetics research platform, oral disease drug R&D platform, and molecular imaging platform. These scientific platforms will allow researchers and scientists to identify novel drug targets and develop more effective treatments for oral diseases covering cavities, pulp diseases, periapical inflammation, oral mucosal diseases, salivary gland diseases, dental-origin tumors, and more.

 

Alta Stomatology's scientific platforms leverage the latest advances in genomics, bioinformatics, and drug discovery to identify potential drug targets and optimize drug candidates for maximum efficacy and safety. By combining these cutting-edge technologies with Alta Stomatology's deep expertise in oral health research, the company aims to bring new and innovative treatments to market faster than ever before.

 

Alta Stomatology's commitment to research and innovation sets it apart as a leader in the field of oral disease research. The company invites researchers, clinicians, and pharmaceutical companies to collaborate with them in the further development and validation of these scientific platforms. Together, they hope to revolutionize the treatment of oral diseases and improve the quality of life for patients around the world.

 

About Alta Stomatology

Alta Stomatology is a leading company specializing in oral disease research. With expertise in a wide range of oral conditions, the company offers a range of services tailored to meet clients’ needs in oral disease research. Alta Stomatology’s services include disease detection and diagnostic solutions, drug development, etc. In addition to its extensive research, Alta Stomatology also offers a series of high-quality products required for oral disease research, including cell culture media, assay kits, antibodies, and more.